Skip to content
Clinical Trials – home

Clinique Pasteur

Verified siteinfo

France 45 Avenue De Lombez, Cs 27617, 31076 Toulouse, France

  • 26 trials recruiting
  • Atrial fibrillation · Prostate cancer · Hormone receptor positive HER2 negative breast cancer
  • Adult patients

About Specializations

Clinique Pasteur in Toulouse, France specialises in clinical trials of conditions such as Atrial fibrillation, Prostate cancer, Hormone receptor positive HER2 negative breast cancer, Acute coronary syndrome, and other specialisations. This site conducts important research.

Main research areas of the site

Oncology

The medical center is at the forefront of oncology research, focusing on innovative treatments for various types of cancer. The center's work in this field is characterized by its commitment to improving patient outcomes through cutting-edge therapies and personalized medicine.

  • Locally advanced anal squamous cell carcinoma
  • Oligometastatic hormone-sensitive prostate cancer
  • ER+/HER2- metastatic breast cancer
  • High-risk biochemically-relapsed prostate adenocarcinoma
  • PD-L1-positive recurrent or metastatic head and neck squamous cell carcinomas

Through its research, the center is pioneering new approaches in chemotherapy, radiotherapy, and immunotherapy, offering hope to patients with challenging cancer diagnoses.

Cardiology

In the realm of cardiology, the center is dedicated to advancing the understanding and treatment of cardiovascular diseases. Its research initiatives are aimed at developing novel therapeutic strategies to manage and prevent heart-related conditions.

  • Hypertension
  • Excessive supraventricular ectopies or short atrial runs
  • Transfemoral trans-aortic valve implantation (TAVI)

The center's contributions to cardiovascular research are instrumental in shaping future clinical practices and improving patient care.

Endocrinology

The center's endocrinology research is focused on understanding the complex interactions of hormones and their impact on health. This research is crucial for developing effective treatments for endocrine disorders.

  • Primary Biliary Cholangitis
  • Prostatic adenocarcinoma with high risk of recurrence

By exploring the underlying mechanisms of endocrine diseases, the center is paving the way for innovative therapies that address the root causes of these conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
45 Avenue De Lombez, Cs 2761731076 ToulouseFrance
Recruiting now
26 trials
Conditions studied
49
Partner status
Verified site

More sites in ToulouseFrance

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

56 clinical trials

Study of personalized treatment using drug combination therapy for young women with early stage hormone receptor-positive breast cancer based on gene expression testing

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer

Study on the Effects of Pegozafermin for Patients with Nonalcoholic Steatohepatitis (NASH) and Fibrosis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BIO89-100
  • Sponsor:F. Hoffmann-La Roche AG

Study of Pegozafermin Treatment for Patients with Liver Cirrhosis due to Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:BIO89-100
  • Sponsor:F. Hoffmann-La Roche AG

Study of Elafibranor for Adults with Primary Biliary Cholangitis

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Elafibranor
  • Sponsor:Ipsen Bioscience Inc.

Docetaxel and Apalutamide in Patients with Metastatic Hormone-Sensitive Prostate Cancer Who Did Not Have a Deep PSA Response After Initial Apalutamide Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Apalutamide

Crohn's disease

Recruiting

One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

InvestigationalNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Guselkumab
  • Sponsor:Groupe D'etude Therapeutique Des Affections Inflammatoires Du Tube Digestif

Comparing sotorasib and pembrolizumab with chemotherapy for patients with advanced non-small cell lung cancer and a KRAS G12C mutation

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Amgen Inc.

Comparing AZD5335 with mirvetuximab soravtansine or a drug combination in patients with platinum-resistant ovarian cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:AZD5335
  • Sponsor:AstraZeneca AB

Study of Trastuzumab Deruxtecan and Pertuzumab for Patients with HER2-Positive Metastatic Breast Cancer Who Have Not Received Prior Treatment

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Solti Group

Testing sacituzumab govitecan and trastuzumab deruxtecan in alternating pattern for patients with HER2-low triple-negative breast cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Sacituzumab Govitecan
  • Sponsor:Unicancer

Study evaluating HER2DX-guided treatment in patients with early-stage HER2-positive breast cancer using trastuzumab, pertuzumab and combination chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.